The Science of Psychedelic Therapy

About the episode:

In this episode, renowned psychedelics researcher Professor Robin Carhart-Harris explores the transformative potential of psychedelics in mental health treatment. Against the backdrop of a global mental health crisis, Prof. Carhart-Harris delves into the neuroscience behind these substances, explaining their unique ability to reset dysfunctional neural circuits associated with various disorders such as depression. The discussion navigates the complex interplay between conventional antidepressants and psychedelic therapies, addressing challenges such as medication discontinuation syndrome and serotonin receptor downregulation. Prof. Carhart-Harris also outlines the emerging framework for integrating psychedelic treatments into mainstream health care, emphasizing the need for clear regulations, professional training, and personalized treatment plans. This episode offers a comprehensive look at the cutting-edge field of psychedelic therapy, its current challenges, and its promising future in revolutionizing mental health care.

About the series:

Atria’s Vanguard Symposia is a lecture series where some of the world’s most compelling researchers translate leading-edge science into medicine. In each episode, top experts share breakthrough science about preventive health care, dive deep into headline-grabbing topics, and take you beyond the buzzwords to explain the latest in longevity science. Our show will arm you with practical information and the tools of discernment to cut through the hype and understand what matters most.

Atria Health and Research Institute aims to accelerate a global shift from reactive sick care to proactive, preventive health care. We work at the forefront of science and technology and we believe a collaborative approach to modern medicine can extend healthy life for all.